Lineage Cell Therapeutics Inc (LCTX)

[DeepDive]

Volume spiked up to 1.3m over 504k.
Interesting.

I usually don’t care of illiquidity at my microcap positions,

But noticed that with continuous ramp up in liquidity comes higher pps range.

Nothing new in the CC for anyone following BTX.

I don’t really care about AGEX distribution, just cheer it’s financial logic and optionality for raising cash.

The only short term horse left in the race is Renevia, and seems that CE mark will arrive within months.

Than revenue growth and EPS growth.

If I was a fund manager now is the time I would enter a position in a special situation portfolio. A clear catalyst for sp appreciation is here.

Perhaps this is the source of the Volume.